Table I.
Group | No. of cases (N) | Hemoglobin (g/l) | Red blood cell count (1×1012/l) | Platelet count (1×109/l) | Leucocyte count (1×109/l) | Lymphocyte absolute value (1×109/l) | Absolute value of mononuclear cells (1×109/l) | Neutrophil absolute value (1×109/l) |
---|---|---|---|---|---|---|---|---|
Primary untreated | 20 | 9.7±4.64 | 3.5±6.4 | 101.2±23.5 | 15.4±8.6 | 10.2±2.5 | 0.92±0.75 | 8.74±3.26 |
Complete remission | 20 | 12.7±2.4 | 4.2±2.1 | 185.7±12.6 | 7.3±2.4 | 4.6±3.1 | 0.54±0.22 | 4.37±1.25 |
Incomplete remission | 21 | 10.7±1.4 | 4.3±1.7 | 199.4±21.7 | 10.4±1.4 | 9.8±1.3 | 0.82±0.33 | 6.27±2.14 |
Relapse after remission | 19 | 9.7±10.9 | 4.8±1.6 | 190.4±28.3 | 9.8±2.1 | 9.6±2.7 | 0.87±0.21 | 8.26±1.06 |
Control group | 20 | 11.8±3.5 | 5.0±1.5 | 201.4±23.9 | 6.8±3.6 | 5.5±3.3 | 0.48±0.73 | 4.22±0.89 |
F value | – | 0.86 | 0.97 | 0.97 | 2.24 | 1.02 | 1.22 | 1.05 |
P-value | >0.05 | >0.05 | >0.05 | <0.05 | <0.05 | <0.05 | <0.05 |
There was no significant difference in the hemoglobin, red blood cell count and platelet count of the primary untreated group, incomplete remission group, and relapse after remission group (P>0.05).